New CMS Incentive Expands Substance Access in Nursing Homes

A recent Centers for Medicare & Medicaid Services (CMS) Innovation Center policy update, effective April 1, 2026, is introducing a significant shift in how some Medicare-certified nursing homes manage resident care.

Under the Substance Access Beneficiary Engagement Incentive (BEI), eligible facilities may incorporate certain eligible hemp-derived products into individualized care plans when prescribed and monitored by qualified clinicians.

While the policy aims to improve quality of life and expand therapeutic options, it also raises important questions about oversight, safety, possible medication errors, and the potential for misuse in vulnerable populations.

About the New Policy

The policy allows clinicians to evaluate whether eligible hemp-derived products can benefit residents when integrated into a structured care plan. Proponents argue that this change reflects a more personalized, patient-centered approach to long-term care, especially for residents dealing with chronic pain, anxiety, or end-of-life conditions.

However, advocates and legal experts warn that without strict safeguards, the expanded use could create new risks for nursing home residents, particularly those already susceptible to neglect or abuse. Improper administration, lack of monitoring, or coercion could lead to adverse health outcomes or exploitation.

Nursing homes already face ongoing challenges related to medication management and resident supervision. Introducing additional substances into care plans increases the complexity of care and emphasizes the need for rigorous oversight to prevent errors, neglect, or intentional misuse.

Signs of Medication Problems

Medication errors and improper sedation have long been cited as forms of nursing home neglect. In some cases, substances have been misused to chemically restrain residents rather than treat legitimate medical conditions.

The new policy heightens the importance of transparency, documentation, and family involvement in care decisions. Families should remain vigilant and actively engaged in their loved one’s care.

Warning signs of abuse or neglect related to substance use may include:

• Inconsistent medication records
• Lack of communication about treatment plans
• Sudden behavioral changes
• Unexplained sedation

As this policy rolls out more broadly, it will be critical for regulators, health care providers, and families to ensure that expanded access translates into better care — not increased risk.

Facilities must adhere to strict clinical guidelines, and any deviation that harms residents could constitute neglect or abuse under the law.

Protecting Nursing Home Residents as New Care Policies Take Effect

As nursing homes begin implementing this policy, the focus must remain where it belongs: on resident safety, dignity, and informed care.

Expanding treatment options may benefit some individuals, but without strong oversight and accountability, it can also open the door to preventable harm.

If something doesn’t feel right, it’s important to trust your instincts. Unexplained changes in a loved one’s condition or gaps in communication should never be ignored. The introduction of new substances into care plans makes active involvement even more critical.

No policy change should come at the expense of vulnerable residents. When facilities fail to meet their duty of care, they can and should be held accountable. The Nursing Home Abuse Center continues to stand with families — offering guidance, resources, and support for those seeking answers and justice.

Call (855) 264-6310 now to get the help that you deserve.